Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Oxford Instruments: share falls after mixed FY-2026 results despite recovery in second half
Oxford Instruments reported a strong recovery in H2 2026 with order intake growth of 8% (H2 +14%) and a particularly strong increase in Advanced Technologies (+28%). For the full year, however, constant-currency revenue declined by 3%, after which the share fell by about 6.9%. Strategic measures such as the sale of the NanoScience business and restructurings improved gross and adjusted operating margins by roughly 30 basis points each. For 2027 the company expects low-single-digit revenue growth in Imaging & Analysis and high double-digit growth in Advanced Technologies, as well as a mid-term target margin of 20%, but sees risks from currency effects and geopolitical uncertainties. » More on de.investing.com
Covalent expands wafer-level semiconductor analysis through partnership with Oxford Instruments
Covalent is partnering with Oxford Instruments to integrate WITec360 Raman technology into its application environment and to provide Raman and photoluminescence workflows for wafers up to 300 mm in diameter. The solution uses dual laser excitation (355 nm and 532 nm) and enables non-destructive, high-resolution mapping of crystallinity, doping, strain and defects. Target markets are production-ready materials such as silicon carbide and gallium nitride to improve yield, process control and failure analysis. » More on de.investing.com
Oxford Instruments confirms full-year outlook after strong order intake and sale of NanoScience
Oxford Instruments maintains its forecast for fiscal 2026 and expects an EBITA of £70.2–73.0m, despite an anticipated negative currency impact of around £5.5m. Since the start of the year the group book-to-bill is 1.2, driven by a currency-adjusted order intake increase of 44.5% in the Advanced Technologies division; the Imaging and Analysis division recovered in Q3 with orders up 2.4% and a book-to-bill of 1.1. The company also completed the sale of its NanoScience business for net £48.5m and in December completed a buy-in for the defined-benefit pension scheme, removing pension contributions from 2027. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | March 2026 | YoY |
|---|---|---|
| Revenue | 271.95m | - |
| Gross profit | 149.42m | - |
| Net profit | 41.42m | - |
| EBITDA | 60.87m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.7bn |
Number of shares | 54.64m |
52-week high/low | €39.93 - €21.29 |
Dividend yield | 0.90% |
Dividends TTM | €0.28 |
Beta | 1.09 |
P/E ratio | 30.21 |
PEG ratio | 0.32 |
P/B ratio | 4.23 |
P/S ratio | 3.35 |
Company profile
Oxford Instruments plc, through its subsidiaries, researches, develops, manufactures, rents, sells, and services tools and systems in the United Kingdom, China, Japan, the United States, Germany, rest of Europe, rest of Asia, and internationally. It operates through e Materials & Characterisation, Research & Discovery, and Service & Healthcare. The company offers atomic force microscopy products; tools for use in research and development across a range of applications, including semiconductors, renewable energy, mining, metallurgy, and forensics; etch and deposition processing equipment and solutions for use in power and RF devices, VCSELs/lasers, 2D materials, augmented reality, biomems, failure analysis, HBLEDs, infrared sensors, MEMS and sensors, and quantum; and low temperature systems comprising wet systems, magnet systems, instrumentation products, and custom and specialty systems. It also provides optical imaging products; and nuclear magnetic resonance (NMR) instruments, including NMR spectrometers, QC/QA analyzers, and rock core analyzers for use in applications, such as agriculture and food, automotive and aviation, building and construction, chemicals, environment, illicit drugs testing, mining and minerals, pharma, polymers, rock core analysis, textiles, and education. In addition, the company offers MRI and CT serving products; scientific cameras spectroscopy solutions, microscopy systems, and software for applications comprising astronomy, bio imaging and life science, energy generation and storage, forensics and environment, photonics, quantum technology, semiconductors, microelectronics, and data storage; and manufacture of x-ray tubes, power supplies, and integrated x-ray sources for analytical, medical imaging, food quality and packaging inspection, and industrial NDT markets. Oxford Instruments plc was founded in 1959 and is headquartered in Abingdon, the United Kingdom.
| Name | OXFORD INSTRUMENTS |
| CEO | John Richard Tyson |
| Headquarters | High Wycombe,
bu United Kingdom |
| Website | |
| Sector | Information Technology |
| Industry | Semiconductors & Semiconductor Equipment |
| IPO | 29/05/2020 |
| Employees | 1,807 |
Ticker symbols
| Exchange | Symbol |
|---|---|
London Stock Exchange | OXIG.L |
Pnk | OXINF |
Frankfurt | OX3.F |
Düsseldorf | OX3.DU |
London | OXIG.L |